Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats
- PMID: 12782212
- DOI: 10.1016/s0031-9384(03)00036-2
Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats
Abstract
The effect of angiotensin-converting enzyme (ACE) inhibitor enalapril (EPL) (2 and 4 mg/kg), angiotensin (AT) II receptor antagonist losartan (LRN) (5 and 10 mg/kg), and anxiolytic drug diazepam (DZP) (0.5 mg/kg) on anxiety parameters were evaluated in experimentally induced renal hypertensive rats (RHR). Renal hypertension was induced in Wistar strain male albino rats weighing 200-250 g by following the method of Goldblatt. The animals having systolic blood pressure more than 180-210 mm Hg were subjected to open-field exploratory behaviour, elevated plus maze behaviour, and social interaction tests of anxiety. The RHR showed hyperactivity in open-field behaviour and anxiogenicity in elevated plus maze and social interaction tests. Losartan (5 and 10 mg/kg) and DZP (0.5 mg/kg) significantly attenuated the hyperactivity and anxiogenic behaviour in experimentally induced hypertensive rats and induced anxiolysis in normotensive rats (NTR). Enalapril reversed the hypertension-induced alteration only at higher dose (4 mg/kg) and failed to show any effect in NTR. It can be concluded that renin angiotensin aldosterone system (RAAS) has a significant role on behaviour, and LRN has shown better effect in reversing the hyperactivity and anxiogenicity in the experimentally induced hypertensive rats, indicating a possible role of AT receptor in the mediation of anxiolysis.
Similar articles
-
Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension.Indian J Exp Biol. 2005 Mar;43(3):241-6. Indian J Exp Biol. 2005. PMID: 15816410
-
Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt.J Hypertens. 2004 Mar;22(3):619-27. doi: 10.1097/00004872-200403000-00026. J Hypertens. 2004. PMID: 15076169
-
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.Biol Pharm Bull. 2000 Feb;23(2):174-81. doi: 10.1248/bpb.23.174. Biol Pharm Bull. 2000. PMID: 10706380
-
Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.Hypertension. 1998 Feb;31(2):692-8. doi: 10.1161/01.hyp.31.2.692. Hypertension. 1998. PMID: 9461242
-
Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.Expert Opin Ther Targets. 2004 Feb;8(1):7-14. doi: 10.1517/14728222.8.1.7. Expert Opin Ther Targets. 2004. PMID: 14996614 Review.
Cited by
-
Strain differences and the role of AT(1) receptor expression in anxiety.Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):51-5. Epub 2010 Dec 26. Int J Mol Epidemiol Genet. 2011. PMID: 21537401 Free PMC article.
-
Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21.Pharmaceuticals (Basel). 2021 Aug 6;14(8):773. doi: 10.3390/ph14080773. Pharmaceuticals (Basel). 2021. PMID: 34451870 Free PMC article.
-
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects.Cardiovasc Res. 2023 May 2;119(3):647-667. doi: 10.1093/cvr/cvac110. Cardiovasc Res. 2023. PMID: 35895876 Free PMC article. Review.
-
Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety.Front Immunol. 2023 Jan 24;13:1053136. doi: 10.3389/fimmu.2022.1053136. eCollection 2022. Front Immunol. 2023. PMID: 36761172 Free PMC article. Review.
-
Evaluation of Anxiolytic Activity of Angiotensin Receptor Blockers Using Actophotometer Test in Wistar Rats.Cureus. 2024 Sep 20;16(9):e69798. doi: 10.7759/cureus.69798. eCollection 2024 Sep. Cureus. 2024. PMID: 39429389 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous